Biostatus
Develops and manufactures fluorescent cell-analysis reagents for research laboratories, screening centres and distributors worldwide
Highlights
- New on EvolcAdded 2026-11-09
About Biostatus
BioStatus invents, develops and manufactures fluorescent reagents for cell-based imaging, cytometry and high-content screening. Products support nuclear staining, viability and cell-health analysis, hypoxia measurement, live-cell tracking and microscopy sample handling.
Its customers include pharmaceutical companies, contract research organizations, academic and not-for-profit institutes, and research facilities. It sells and distributes products directly and through channel partners worldwide.
BioStatus manufactures its products in the UK to the ISO 9001:2015 quality standard. The registered company was founded in 1995 and is headquartered in Shepshed, United Kingdom.
Product: Fluorescent reagents and hydrogel mountants for cell analysis, cytometry, imaging and screening workflows.
Jobs at Biostatus
Leadership
- Stefan Ogrodzinski · Director / CEOSource: company website
More biotech & pharma companies
Biovara
Developing an oral therapy for lung cancer cough for patients with advanced lung cancerYoung companyNew on EvolcBiowaived
Biopharmaceutics consultancy and dissolution laboratory services for pharma and biotech drug product developmentYoung companyNew on EvolcBlackfinbio
Develops gene therapies for patients with rare and other central nervous system diseasesYoung companyNew on EvolcBlacksheep Sciences
Engineering and product-development services for life science and biotech teams building instruments and microfluidic platformsYoung companyNew on EvolcBlue Earth Diagnostics
Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patientsNew on EvolcSalary transparentBlue Earth Therapeutics
Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
E-commerce
- WooCommerceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.